Cell-Easy is a stem cell Contract Development and Manufacturing Organisation (CDMO) that provides quick and easy access to ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects.

Their production process has been optimised under cGMP conditions and inspected by the French National Agency of Medicine and Health Products Safety (ANSM), in order to be scalable and guarantee optimal product safety, quality and efficacy for patients.